Clozapine in China: a review and preview of US/PRC collaboration.
Potter
W Z
WZ
Department of Health and Human Services, National Institute of Mental Health, Bethesda, MD 20892.
Ko
G N
GN
Zhang
L D
LD
Yan
W W
WW
D000328:Adult; D002681:China; D002746:Chlorpromazine / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use*; D003984:Dibenzazepines / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006719:Homovanillic Acid / Q000097:blood; D006801:Humans; D007391:International Cooperation; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy*; D014481:United States
D003984:Dibenzazepines; D003024:Clozapine; D002746:Chlorpromazine; D006719:Homovanillic Acid